Global Oocyte Cryopreservation Market Overview:
Oocyte cryopreservation is a promising adjunct to human-assisted reproductive technology. Slow rate freezing has been the cryopreservation standard for the storage of sperm, embryos, and, subsequently, oocytes. Moreover, many studies indicated that acceptable oocyte survival, in vitro fertilization, normal embryos, and adequate blastocyst development can be achieved with oocyte cryopreservation, this has projected the growth of the global oocyte cryopreservation market in the forecast period. Some of the players profiled in the study are Anova Fertility (Canada), Manchester Fertility (United Kingdom), CCRM IVF (United States), CREATE Fertility (United Kingdom), Extend Fertility (United States), Kindbody (United States), HRC Fertility (United States), London Women's Clinic (United Kingdom), IVF Australia (Australia) and Prelude Fertility (United States).
On the basis of geography, the market of Oocyte Cryopreservation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Component, the sub-segment i.e. Cryopreservation Media will boost the Oocyte Cryopreservation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Biobanks will boost the Oocyte Cryopreservation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increasing Number of Egg, Sperm, or Embryo Donors
- Raising Awareness about the Procedure among Individuals
- Growing Numbers of Women Undergo Oocyte Cryopreservation for Both Medical and Social Reasons
- Advancements in Freezing technology are Likely to Increase the Use of Donor Eggs, Sperm, or Embryo for Fertility Treatment
- High Cost Associated with Oocyte Cryopreservation
- Increased Emphasis on R&D Investments and Drug Discovery, Several Small Companies have Resorted to Outsourcing their Drug Discovery Process to Subcontract Laboratories
- Ice Formation and Damage to Oocyte Cryopreservation
- Low Awareness about Cryogenic Offerings in Developing Countries and Rural Areas
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Target Audience:Oocyte Cryopreservation Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Oocyte Cryopreservation market on the basis of product [Slow-cooling Method and Flash-freezing Process (Vitrification)] , application [25-30-Year-Old Female, 30-35-Year-Old Female, 35-40-Year-Old Female and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Oocyte Cryopreservation market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Oocyte Cryopreservation industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Reproductive Biology Associates (United States), Virtus Health (Australia), Mayo Clinic (United States), Pacific Fertility Center-Los Angeles (PFCLA) (United States), Monash IVF (Australia), Shady Grove Fertility (United States), Melbourne IVF (Australia) and San Diego Fertility Center (SDFC) (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Oocyte Cryopreservation market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.